BICLUSTER_ID : UPREG-318
PATHOGENS /2/ : brucella neotomae,burkholderia pseudomallei
TARGETS /11/ : CCL2, ACSL1, PEBP1, TNFRSF1B, PPARG, HSP90AA1, AURKA, MMP3, IL1B, PTGS2, ICAM1
Gene SetLeading Edge Genes
NETPATH IL 4 PATHWAY DOWNNPAS2, CDKN1A, CCL2, NFKBIA, MMP3, GEM, PTGS2, ICAM1, CXCL2
NCI AURORA B PATHWAYKIF20A, PPP2R5D, BUB1, AURKB, CENPA, STMN1, SMC2, AURKA, CBX5, RACGAP1, NCL, KIF23, PEBP1, RASA1, CDCA8, BIRC5, NPM1
GERY CEBP TARGETSRGS2, ATF3, ACSL1, ELOVL6, HBEGF, PPARG
SA MMP CYTOKINE CONNECTIONIL1B, TNFRSF1B
NCI ERBB NETWORK PATHWAYHBEGF, ERBB4, HSP90AA1
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
SCIAN CELL CYCLE TARGETS OF TP53 AND TP73 DN
LI WILMS TUMOR VS FETAL KIDNEY 1 DN
MAHAJAN RESPONSE TO IL1A UP
LEE EARLY T LYMPHOCYTE UP
HORIUCHI WTAP TARGETS DN
CHANG CORE SERUM RESPONSE UP
NEWMAN ERCC6 TARGETS DN
OUELLET OVARIAN CANCER INVASIVE VS LMP UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN
NCI VIRAL MESSENGER RNA SYNTHESISSNRPE, FUS, SFRS3, HNRPD, SNRPD1, POLR2H, SNRPD3, POLR2K, SNRPD2, U2AF1, HNRPA3, PCBP1, POLR2J
LINDSTEDT DENDRITIC CELL MATURATION A
ELVIDGE HYPOXIA UP
XU HGF TARGETS REPRESSED BY AKT1 UP
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UPCCL17, KLF2, CXCL2, CCL4
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
KOBAYASHI EGFR SIGNALING 24HR DN
CORUM PA700 COMPLEXPSMC5, PSMD14, PSMD7, PSMD6, PSMD12, PSMD13, PSMC1, PSMD4
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
PUJANA CHEK2 PCC NETWORK
HINATA NFKB TARGETS KERATINOCYTE UP
SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP
DORN ADENOVIRUS INFECTION 48HR DN
AMIT SERUM RESPONSE 60 MCF10A
DUTTA APOPTOSIS VIA NFKB
DORSEY GAB2 TARGETS
DIRMEIER LMP1 RESPONSE EARLY
WOTTON RUNX TARGETS UP
REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
MORI IMMATURE B LYMPHOCYTE DN
DANG MYC TARGETS UP
TAVOR CEBPA TARGETS UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
BLUM RESPONSE TO SALIRASIB DN
RHEIN ALL GLUCOCORTICOID THERAPY DN
NAGASHIMA NRG1 SIGNALING DN
AMIT SERUM RESPONSE 120 MCF10A
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINED IN MONOCYTE DN
GEISS RESPONSE TO DSRNA UP
NCI MRNA SPLICING MAJOR PATHWAYSNRPE, SFRS9, SFRS3, FUS, MAGOH, HNRPD, SNRPD3, WDR57, POLR2K, HNRPA3, SF3A3, PCBP1, PABPN1, POLR2J, SNRPA1, NUDT21, SNRPD1, DHX9, POLR2H, PCBP2, SF3B2, SF3B1, SNRPD2, U2AF1
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
FOURNIER ACINAR DEVELOPMENT LATE 2
ZHOU INFLAMMATORY RESPONSE FIMA UP
MORI LARGE PRE BII LYMPHOCYTE UP
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
NAGASHIMA EGF SIGNALING UP
MISSIAGLIA REGULATED BY METHYLATION DN
NCI MRNA SPLICING MINOR PATHWAYPOLR2H, SNRPD3, SNRPE, WDR57, POLR2K, SNRPD2, SNRPD1, POLR2J
AMIT EGF RESPONSE 60 MCF10A
BENPORATH PROLIFERATION
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
WHITEFORD PEDIATRIC CANCER MARKERS
RHODES UNDIFFERENTIATED CANCER
BIOCARTA EPONFKB PATHWAY
NAKAYAMA SOFT TISSUE TUMORS PCA2 DN
TARTE PLASMA CELL VS PLASMABLAST DN
DORN ADENOVIRUS INFECTION 32HR DN
ZHAN MULTIPLE MYELOMA PR UP
CROONQUIST STROMAL STIMULATION UP
SHARMA PILOCYTIC ASTROCYTOMA LOCATION UP
REACTOME MRNA SPLICING
HALMOS CEBPA TARGETS UP
MARKEY RB1 ACUTE LOF DN
REACTOME PHASE 1 FUNCTIONALIZATION OF COMPOUNDS
KAUFFMANN MELANOMA RELAPSE UP
MAHADEVAN RESPONSE TO MP470 DN
HARRIS HYPOXIA
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
CAIRO HEPATOBLASTOMA CLASSES UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
SCHLOSSER MYC TARGETS REPRESSED BY SERUM
BIOCARTA PPARA PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
DAUER STAT3 TARGETS UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
FERRANDO T ALL WITH MLL ENL FUSION DN
MENSE HYPOXIA UPNFIL3, ATF3, HK2, UFM1, ADM, BHLHB2, SOD2, TIPARP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
WINNEPENNINCKX MELANOMA METASTASIS UP
DAZARD UV RESPONSE CLUSTER G2
CHEN HOXA5 TARGETS 9HR UP
SCHUHMACHER MYC TARGETS UP
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
MANALO HYPOXIA DN
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BROWNE HCMV INFECTION 4HR UP
REACTOME MRNA SPLICING MINOR PATHWAY
BIDUS METASTASIS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
YU MYC TARGETS UP
KIM WT1 TARGETS UP
REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
KINSEY TARGETS OF EWSR1 FLII FUSION UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE DN
CAFFAREL RESPONSE TO THC 24HR 5 DN
HESS TARGETS OF HOXA9 AND MEIS1 DN
CHANG CYCLING GENES
ELVIDGE HYPOXIA BY DMOG UP
DASU IL6 SIGNALING UP
WONG EMBRYONIC STEM CELL CORE
RHODES CANCER META SIGNATURE
FARMER BREAST CANCER CLUSTER 2
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
RICKMAN HEAD AND NECK CANCER E
WATTEL AUTONOMOUS THYROID ADENOMA DN
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
KIM WT1 TARGETS 8HR UP
GRAHAM CML DIVIDING VS NORMAL DIVIDING DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
burkholderia pseudomalleibrucella neotomaeGeneSet Name
0.16712 0.00269NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.07337NCI_AURORA_B_PATHWAY
0.00015 0.18522GERY_CEBP_TARGETS
0.13793 0.10715SA_MMP_CYTOKINE_CONNECTION
0.00741 0.13128NCI_ERBB_NETWORK_PATHWAY
0.00000 0.00862GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.00002 0.03682GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.14815SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.00000 0.19269LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.01913 0.16767MAHAJAN_RESPONSE_TO_IL1A_UP
0.00000 0.17236LEE_EARLY_T_LYMPHOCYTE_UP
0.00000 0.15769HORIUCHI_WTAP_TARGETS_DN
0.00000 0.00137CHANG_CORE_SERUM_RESPONSE_UP
0.08011 0.13116NEWMAN_ERCC6_TARGETS_DN
0.00000 0.00560OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.05958 0.11314REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00000 0.17842MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.00000 0.00378NCI_VIRAL_MESSENGER_RNA_SYNTHESIS
0.00750 0.00010LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.02727 0.04424ELVIDGE_HYPOXIA_UP
0.06915 0.03884XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.00290 0.01260AMIT_EGF_RESPONSE_40_HELA
0.16021 0.01290NETPATH_IL_7_PATHWAY_UP
0.12979 0.01038THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00000 0.06164KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.06173 0.01910CORUM_PA700_COMPLEX
0.16014 0.16364TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00000 0.00636PUJANA_CHEK2_PCC_NETWORK
0.00143 0.09086HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00000 0.00237SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.14963 0.11822DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00292 0.11766AMIT_SERUM_RESPONSE_60_MCF10A
0.07914 0.00644DUTTA_APOPTOSIS_VIA_NFKB
0.00738 0.09248DORSEY_GAB2_TARGETS
0.04849 0.00214DIRMEIER_LMP1_RESPONSE_EARLY
0.19046 0.08266WOTTON_RUNX_TARGETS_UP
0.00000 0.00935REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.10469 0.00575REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00909 0.01309ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.05647 0.01819ONDER_CDH1_TARGETS_3_DN
0.00000 0.01477GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00027 0.02726AMIT_EGF_RESPONSE_120_HELA
0.00000 0.09810MORI_IMMATURE_B_LYMPHOCYTE_DN
0.00000 0.06044DANG_MYC_TARGETS_UP
0.08082 0.11809TAVOR_CEBPA_TARGETS_UP
0.00209 0.03432SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00000 0.08362BLUM_RESPONSE_TO_SALIRASIB_DN
0.00000 0.02657RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
0.12228 0.18134NAGASHIMA_NRG1_SIGNALING_DN
0.02599 0.11404AMIT_SERUM_RESPONSE_120_MCF10A
0.00000 0.04591SESTO_RESPONSE_TO_UV_C3
0.13600 0.03242VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.05129 0.05694TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.11502 0.01183GEISS_RESPONSE_TO_DSRNA_UP
0.00000 0.00145NCI_MRNA_SPLICING___MAJOR_PATHWAY
0.00009 0.16491GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00000 0.13378FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.00000 0.05928ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00000 0.07216MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.00000 0.02738ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.00000 0.05899TIAN_TNF_SIGNALING_VIA_NFKB
0.09754 0.07619HUMMEL_BURKITTS_LYMPHOMA_DN
0.00000 0.01336NAGASHIMA_EGF_SIGNALING_UP
0.00000 0.16069MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.00000 0.00562NCI_MRNA_SPLICING___MINOR_PATHWAY
0.00375 0.02489AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.04383BENPORATH_PROLIFERATION
0.02392 0.17773KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.01125 0.12949CHEN_HOXA5_TARGETS_6HR_UP
0.01050 0.00128OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00000 0.11385WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.00000 0.08875RHODES_UNDIFFERENTIATED_CANCER
0.19387 0.17788BIOCARTA_EPONFKB_PATHWAY
0.03967 0.08144NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.00000 0.00389TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.19819 0.06343DORN_ADENOVIRUS_INFECTION_32HR_DN
0.00000 0.15111ZHAN_MULTIPLE_MYELOMA_PR_UP
0.02367 0.00132CROONQUIST_STROMAL_STIMULATION_UP
0.15269 0.18216SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.00000 0.00153REACTOME_MRNA_SPLICING
0.11122 0.07569HALMOS_CEBPA_TARGETS_UP
0.00000 0.01124MARKEY_RB1_ACUTE_LOF_DN
0.07469 0.07172REACTOME_PHASE_1_FUNCTIONALIZATION_OF_COMPOUNDS
0.00000 0.12768KAUFFMANN_MELANOMA_RELAPSE_UP
0.00025 0.00665MAHADEVAN_RESPONSE_TO_MP470_DN
0.16949 0.17495HARRIS_HYPOXIA
0.14993 0.06990GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00000 0.03264CAIRO_HEPATOBLASTOMA_CLASSES_UP
0.00280 0.11317TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00002 0.06679NAGASHIMA_NRG1_SIGNALING_UP
0.03675 0.01093SOUCEK_MYC_TARGETS
0.00000 0.13113SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.18858 0.14321BIOCARTA_PPARA_PATHWAY
0.05436 0.01515TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.14983 0.09849MAHADEVAN_RESPONSE_TO_MP470_UP
0.05896 0.02413FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00256 0.00155DAUER_STAT3_TARGETS_UP
0.02735 0.04575ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.16167FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.00659 0.06879MENSE_HYPOXIA_UP
0.17112 0.09764ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.02574 0.04600AMIT_EGF_RESPONSE_60_HELA
0.00000 0.00770WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.02586 0.00657DAZARD_UV_RESPONSE_CLUSTER_G2
0.03571 0.02011CHEN_HOXA5_TARGETS_9HR_UP
0.00000 0.04605SCHUHMACHER_MYC_TARGETS_UP
0.06818 0.03264AMIT_SERUM_RESPONSE_40_MCF10A
0.01261 0.00041SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.11638MANALO_HYPOXIA_DN
0.00000 0.07552GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00139 0.00387ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.02223 0.00980BROWNE_HCMV_INFECTION_4HR_UP
0.00000 0.00856REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.00000 0.10679BIDUS_METASTASIS_UP
0.00000 0.00059HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00000 0.00365YU_MYC_TARGETS_UP
0.05021 0.10627KIM_WT1_TARGETS_UP
0.02548 0.01050REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.00000 0.05710FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.00000 0.03267CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.00019 0.00256UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00000 0.07247KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
0.00000 0.10986GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.00000 0.12453CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.08705 0.15914HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.08251CHANG_CYCLING_GENES
0.03396 0.11243ELVIDGE_HYPOXIA_BY_DMOG_UP
0.03694 0.12777DASU_IL6_SIGNALING_UP
0.00000 0.00159WONG_EMBRYONIC_STEM_CELL_CORE
0.00000 0.06329RHODES_CANCER_META_SIGNATURE
0.00000 0.11344FARMER_BREAST_CANCER_CLUSTER_2
0.00000 0.00010GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.02880 0.00123OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.03179 0.17310RICKMAN_HEAD_AND_NECK_CANCER_E
0.19540 0.08584WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.01688 0.10655PRAMOONJAGO_SOX4_TARGETS_UP
0.09787 0.16797PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00345 0.15073KIM_WT1_TARGETS_8HR_UP
0.00094 0.15801GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN